USA – Becton, Dickinson and Company (BD) has unveiled its latest advancement in healthcare technology with the introduction of SiteRite 9, an all-in-one vascular access ultrasound system.
This innovative system aims to enhance clinician efficiency during the insertion of IV lines, central venous catheters, peripherally inserted central catheters (PICCs), and other vascular access devices.
The SiteRite 9 system boasts ‘industry-leading’ catheter placement tools and technologies, providing crucial support to clinicians during the insertion of various vascular access devices.
Its 15.6-inch touchscreen has been updated for improved image quality, ensuring ease of use for physicians.
BD’s Medication Delivery Solutions worldwide president, Eric Borin, emphasized the system’s potential impact: “Our latest innovation in ultrasound technology is designed to make vascular access care delivery easier and more efficient for clinicians — whether they’ve been on the job for years or are new to the field.”
The system integrates advanced visualization tools, including the Cue Needle monitoring system, offering continuous, real-time needle monitoring, and the Sherlock 3CG+ Tip Confirmation System, ensuring precise catheter tip navigation and position.
One of the standout features of SiteRite 9 is its intelligent, networked technologies, which include vessel assessment tools.
These tools automatically detect the vessel and pair with vessel measurement tools to assist clinicians in selecting the most suitable catheter. This not only enhances accuracy but also streamlines the insertion process.
Moreover, the system supports clinician workflow with record transfer, auto-filling capabilities, and patient data lookup, facilitating seamless information collection.
The SiteRite 9 system, which received 510(k) clearance in September 2023, is now commercially available in the United States.
This launch aligns with BD’s “One-Stick Hospital Stay” initiative, introduced over two years ago to transform the patient experience by minimizing the need for repeated needlesticks and improving insertion success rates on the first attempt.
Eric Borin reiterated the significance of this advancement: “By combining our decades of leadership in vascular access with voice-of-the-customer enhancements, we’ve developed a best-in-class solution to aid in insertion success on the first attempt and reduce the need for repeated needlesticks to deliver a better care experience for everyone involved.”
This announcement follows BD’s recent unveiling of the PIVO Pro needle-free blood collection device, demonstrating the company’s commitment to advancing patient care and clinical efficiency.
The PIVO Pro allows blood samples to be drawn directly from a patient’s peripheral IV line, showcasing BD’s continuous efforts to innovate and address challenges in healthcare delivery.
BD’s SiteRite 9 and PIVO Pro collectively represent a significant leap forward in streamlining medical procedures and enhancing the overall patient care experience.